Importantly, we uncovered that circHMGCS1–016 overexpression negatively regulates anti-tumor immunity through elevating the expression of CD73 and GAL-8 protein simultaneously, which further depressed CD8+ T cells and CD4+ T cells and reduced the anti-tumor activity of immune cells. Here, CD8A is linked to neoplasm.